Acute generalized exanthematous pustulosis (AGEP) secondary to imatinib in a patient with chronic myeloid leukaemia

Clin Exp Dermatol. 2015 Dec;40(8):926-7. doi: 10.1111/ced.12479. Epub 2014 Sep 30.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acute Generalized Exanthematous Pustulosis / etiology*
  • Acute Generalized Exanthematous Pustulosis / pathology
  • Aged
  • Antineoplastic Agents / adverse effects*
  • Drug Eruptions / etiology*
  • Drug Eruptions / pathology
  • Female
  • Humans
  • Imatinib Mesylate / adverse effects*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*

Substances

  • Antineoplastic Agents
  • Imatinib Mesylate